Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 27 04:00PM ET
23.05
Dollar change
-0.16
Percentage change
-0.69
%
IndexRUT P/E- EPS (ttm)-2.92 Insider Own1.67% Shs Outstand64.41M Perf Week-10.03%
Market Cap1.48B Forward P/E- EPS next Y-2.74 Insider Trans-8.26% Shs Float63.34M Perf Month-8.13%
Income-165.00M PEG- EPS next Q-0.67 Inst Own101.19% Short Float14.78% Perf Quarter10.45%
Sales62.30M P/S23.83 EPS this Y-4.40% Inst Trans-4.24% Short Ratio13.03 Perf Half Y56.80%
Book/sh5.76 P/B4.00 EPS next Y1.08% ROA-38.30% Short Interest9.36M Perf Year177.04%
Cash/sh6.88 P/C3.35 EPS next 5Y- ROE-52.33% 52W Range4.22 - 26.31 Perf YTD123.35%
Dividend Est.- P/FCF- EPS past 5Y-59.00% ROI-42.14% 52W High-12.39% Beta2.23
Dividend TTM- Quick Ratio5.57 Sales past 5Y27.29% Gross Margin75.73% 52W Low446.21% ATR (14)1.27
Dividend Ex-Date- Current Ratio5.57 EPS Y/Y TTM1.63% Oper. Margin-287.47% RSI (14)44.27 Volatility5.07% 5.12%
Employees284 Debt/Eq0.08 Sales Y/Y TTM2.25% Profit Margin-264.84% Recom1.33 Target Price29.67
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q-59.61% Payout- Rel Volume0.31 Prev Close23.21
Sales Surprise-45.30% EPS Surprise-11.85% Sales Q/Q-60.58% EarningsJul 11 AMC Avg Volume718.75K Price23.05
SMA20-5.60% SMA500.14% SMA20045.31% Trades Volume225,187 Change-0.69%
Date Action Analyst Rating Change Price Target Change
Sep-06-24Resumed Robert W. Baird Outperform $26
Jul-31-24Initiated Truist Buy $36
Jun-26-23Resumed Oppenheimer Outperform $25
Mar-09-23Initiated Barclays Overweight $20
Feb-28-23Initiated Oppenheimer Outperform $25
Oct-11-22Initiated Morgan Stanley Equal-Weight $11
May-31-22Upgrade Wells Fargo Equal Weight → Overweight $25
Feb-10-22Initiated Wells Fargo Equal Weight $28
Dec-29-21Initiated H.C. Wainwright Buy $62
Oct-14-21Initiated SVB Leerink Outperform $50
Sep-24-24 09:15AM
Sep-06-24 07:00AM
Sep-05-24 12:01AM
Sep-02-24 05:22PM
Aug-29-24 07:00AM
12:50AM Loading…
Aug-27-24 12:50AM
Jul-25-24 09:55AM
Jul-16-24 12:00PM
Jul-11-24 05:10PM
04:00PM
Jul-08-24 07:00AM
Jun-20-24 07:02PM
05:26PM
Jun-19-24 05:05AM
Jun-17-24 04:06PM
08:45AM Loading…
08:45AM
07:40AM
Jun-16-24 05:30AM
Jun-10-24 07:00AM
May-29-24 07:00AM
May-28-24 07:00AM
May-20-24 04:41PM
04:00PM
10:21AM
May-14-24 10:00AM
07:39AM
May-07-24 07:00AM
Apr-16-24 06:21PM
Apr-11-24 11:38PM
04:00PM
11:53AM Loading…
Apr-10-24 11:53AM
09:29AM
08:31AM
08:10AM
07:00AM
Apr-09-24 01:15PM
07:00AM
Apr-03-24 07:00AM
Apr-02-24 07:00AM
Mar-25-24 07:00AM
Mar-20-24 09:40AM
Mar-11-24 07:00AM
Mar-06-24 04:00PM
Mar-05-24 04:30PM
Feb-23-24 06:20AM
Feb-16-24 07:04PM
Feb-15-24 05:10PM
04:00PM
Feb-01-24 04:01PM
10:01AM
Jan-16-24 04:01PM
Jan-08-24 07:00AM
Jan-02-24 04:01PM
Dec-21-23 05:01PM
Dec-13-23 04:32PM
Dec-11-23 12:00PM
Dec-04-23 04:01PM
Nov-07-23 04:01PM
Nov-02-23 09:00AM
Nov-01-23 04:01PM
Oct-18-23 09:35AM
Oct-14-23 06:01AM
Oct-12-23 05:15PM
04:01PM
Oct-11-23 07:09AM
Oct-05-23 09:35AM
Oct-04-23 09:35AM
Sep-28-23 10:00AM
Sep-20-23 09:30AM
Sep-15-23 12:00PM
09:55AM
Sep-11-23 12:10PM
Sep-08-23 05:32AM
Sep-07-23 07:00AM
Aug-31-23 10:12PM
04:01PM
Aug-02-23 05:01AM
Jul-24-23 09:55AM
Jul-15-23 08:12AM
Jul-13-23 05:15PM
04:01PM
Jul-11-23 10:00AM
Jun-29-23 10:00AM
Jun-14-23 07:00AM
May-25-23 06:28AM
May-24-23 09:55AM
May-09-23 04:01PM
May-04-23 09:55AM
Apr-19-23 06:05AM
Apr-18-23 09:55AM
Apr-17-23 02:30PM
Apr-13-23 05:15PM
04:01PM
Apr-11-23 04:01PM
Mar-30-23 10:00AM
Mar-21-23 10:05AM
03:49AM
Mar-20-23 12:17PM
09:00AM
08:30AM
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rape, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ring ChristineChief Legal OfficerSep 03 '24Option Exercise4.669,05042,19933,642Sep 03 05:33 PM
Ring ChristineChief Legal OfficerSep 03 '24Sale24.949,050225,73624,592Sep 03 05:33 PM
CHRISTINE RINGOfficerSep 03 '24Proposed Sale25.209,050228,060Sep 03 04:28 PM
Ring ChristineChief Legal OfficerAug 26 '24Option Exercise6.089,87060,04634,462Aug 26 06:23 PM
Ring ChristineChief Legal OfficerAug 26 '24Sale25.019,870246,84324,592Aug 26 06:23 PM
van Houte HansChief Financial OfficerAug 26 '24Sale25.2220,000504,37031,002Aug 26 05:41 PM
JOHANNES VAN HOUTEOfficerAug 26 '24Proposed Sale24.0220,000480,400Aug 26 04:25 PM
CHRISTINE RINGOfficerAug 26 '24Proposed Sale24.029,870237,077Aug 26 04:24 PM
van Houte HansChief Financial OfficerAug 01 '24Sale21.453,47774,57651,002Aug 01 07:06 PM
Ring ChristineChief Legal OfficerAug 01 '24Option Exercise1.865,76010,71430,352Aug 01 07:06 PM
Ring ChristineChief Legal OfficerAug 01 '24Sale21.435,760123,45924,592Aug 01 07:06 PM
JOHANNES VAN HOUTEOfficerAug 01 '24Proposed Sale21.883,47776,077Aug 01 04:31 PM
CHRISTINE RINGOfficerAug 01 '24Proposed Sale21.885,760126,029Aug 01 04:26 PM
Hansen GwennChief Scientific OfficerJul 30 '24Option Exercise0.008,957048,558Jul 30 07:06 PM
Hansen GwennChief Scientific OfficerJul 30 '24Sale20.673,40870,43645,150Jul 30 07:06 PM
Ring ChristineChief Legal OfficerJul 30 '24Option Exercise0.007,674027,512Jul 30 07:06 PM
Ring ChristineChief Legal OfficerJul 30 '24Sale20.672,92060,35024,592Jul 30 07:06 PM
van Houte HansChief Financial OfficerJul 30 '24Option Exercise0.008,636056,969Jul 30 07:06 PM
van Houte HansChief Financial OfficerJul 30 '24Sale20.672,49051,46354,479Jul 30 07:06 PM
Ring ChristineChief Legal OfficerJul 01 '24Option Exercise1.865,76010,71425,598Jul 01 06:35 PM
Ring ChristineChief Legal OfficerJul 01 '24Sale20.815,760119,83719,838Jul 01 06:35 PM
van Houte HansChief Financial OfficerJun 20 '24Sale20.0120,000400,21648,333Jun 20 04:58 PM
Ring ChristineChief Legal OfficerJun 13 '24Option Exercise1.861,8643,46721,702Jun 13 06:39 PM
Ring ChristineChief Legal OfficerJun 13 '24Sale17.021,86431,72119,838Jun 13 06:39 PM
Ring ChristineChief Legal OfficerJun 12 '24Option Exercise1.861,9003,53421,738Jun 12 07:30 PM
Ring ChristineChief Legal OfficerJun 12 '24Sale17.011,90032,31919,838Jun 12 07:30 PM
Ring ChristineChief Legal OfficerJun 05 '24Option Exercise1.8640074420,238Jun 05 06:01 PM
Ring ChristineChief Legal OfficerJun 05 '24Sale17.004006,80119,838Jun 05 06:01 PM
Ring ChristineChief Legal OfficerJun 03 '24Option Exercise1.861,5962,96921,434Jun 03 06:36 PM
Ring ChristineChief Legal OfficerJun 03 '24Sale17.011,59627,15319,838Jun 03 06:36 PM
van Houte HansChief Financial OfficerMay 02 '24Sale12.833,49944,87868,333May 02 06:01 PM
van Houte HansChief Financial OfficerApr 30 '24Option Exercise0.004,886073,219Apr 30 06:33 PM
van Houte HansChief Financial OfficerApr 30 '24Sale12.041,38716,70371,832Apr 30 06:33 PM
Hansen GwennChief Scientific OfficerApr 30 '24Option Exercise0.005,206041,608Apr 30 06:33 PM
Hansen GwennChief Scientific OfficerApr 30 '24Sale12.042,00724,16939,601Apr 30 06:33 PM
Ring ChristineChief Legal OfficerApr 30 '24Option Exercise0.003,924021,351Apr 30 06:33 PM
Ring ChristineChief Legal OfficerApr 30 '24Sale12.041,51318,22019,838Apr 30 06:33 PM
van Houte HansChief Financial OfficerFeb 16 '24Sale10.026,81268,22368,333Feb 16 07:20 PM
van Houte HansChief Financial OfficerJan 30 '24Option Exercise0.004,886076,816Jan 30 06:53 PM
van Houte HansChief Financial OfficerJan 30 '24Sale7.991,67113,35275,145Jan 30 06:53 PM
Hansen GwennChief Scientific OfficerJan 30 '24Option Exercise0.005,207038,736Jan 30 06:52 PM
Hansen GwennChief Scientific OfficerJan 30 '24Sale7.992,33418,64936,402Jan 30 06:52 PM
Ring ChristineChief Legal OfficerJan 30 '24Option Exercise0.003,924019,187Jan 30 06:52 PM
Ring ChristineChief Legal OfficerJan 30 '24Sale7.991,76014,06317,427Jan 30 06:52 PM
van Houte HansChief Financial OfficerDec 20 '23Sale10.003,54135,42171,930Dec 21 05:19 PM
van Houte HansChief Financial OfficerDec 19 '23Sale10.0010,906109,09375,471Dec 20 04:55 PM
van Houte HansChief Financial OfficerOct 30 '23Option Exercise0.004,886087,457Nov 01 04:41 PM
van Houte HansChief Financial OfficerOct 31 '23Sale5.201,0805,61386,377Nov 01 04:41 PM
Ring ChristineChief Legal OfficerOct 30 '23Option Exercise0.003,924016,495Nov 01 04:40 PM
Ring ChristineChief Legal OfficerOct 31 '23Sale5.201,2326,40315,263Nov 01 04:40 PM
Hansen GwennChief Scientific OfficerOct 30 '23Option Exercise0.005,207035,162Nov 01 04:40 PM
Hansen GwennChief Scientific OfficerOct 31 '23Sale5.201,6338,48733,529Nov 01 04:40 PM